Gabapentin: pharmacokinetics, efficacy, and safety.

@article{Beydoun1995GabapentinPE,
  title={Gabapentin: pharmacokinetics, efficacy, and safety.},
  author={Ahmad A Beydoun and Basim M. Uthman and J. Chris Sackellares},
  journal={Clinical neuropharmacology},
  year={1995},
  volume={18 6},
  pages={469-81}
}
Gabapentin is a new antiepileptic drug (AED) with an attractive pharmacokinetic profile. It is absorbed by an active and saturable transport system, and has a high volume of distribution. Gabapentin is not bound to plasma proteins, does not induce hepatic enzymes and is not metabolized. At steady state, it has a half-life of 6-8 h, and is eliminated unchanged by renal route with a plasma clearance proportional to the creatinine clearance. It is devoid of significant drug-drug interactions when… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Pharmacokinetic profile and behavioral effects of gabapentin in the horse.

Journal of veterinary pharmacology and therapeutics • 2010
View 6 Excerpts
Highly Influenced

Voltage-dependent calcium channels.

General physiology and biophysics • 2005
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…